Innate immunity to pneumococcal infection of the central nervous system depends on toll-like receptor (TLR) 2 and TLR4.

BACKGROUND Recent studies have suggested that, in addition to Toll-like receptor (TLR) 2, other pattern recognition receptors mediate activation of the immune response after infection of the central nervous system (CNS) with Streptococcus pneumoniae (SP). METHODS Using a mouse meningitis model, we investigated the influence of TLR4 single deficiency (TLR4(-/-)), TLR2/TLR4 double deficiency (TLR2/4(-/-)), and TLR2/TLR4/TLR9 triple deficiency (TLR2/4/9(-/-)) on the immune response of the CNS to SP infection. To identify the cell populations that mediate the responses to SP, we generated TLR2/4(-/-)-wild-type (wt) bone marrow (BM) chimeras. RESULTS Compared with infected wt mice, infected TLR2/4(-/-) and TLR2/4/9(-/-) mice had similar reductions in brain cytokine levels, pleocytosis, and cerebral pathologic findings, whereas no such effect was noted in infected TLR4(-/-) mice. The attenuated immune response was paralleled by an impaired host defense that resulted in worsening of disease. Analysis of the chimeric mice after infection showed that mere TLR2/4 deficiency, either of radioresistant cells or of transplanted BM-derived cells, was sufficient to mount a substantial cerebral immune response, such as that noted in wt mice. CONCLUSION In murine SP meningitis, TLR2 and TLR4 expressed on radioresistant and transplanted BM-derived cells were major cellular sensors of invading SP inducing inflammatory responses.

[1]  R. Lyons,et al.  Toll‐like receptor‐4‐mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors , 2008, Immunology.

[2]  Linden J. Gearing,et al.  Glucocorticoids Inhibit IRF3 Phosphorylation in Response to Toll-like Receptor-3 and -4 by Targeting TBK1 Activation* , 2008, Journal of Biological Chemistry.

[3]  P. Andrew,et al.  Streptococcus pneumoniae deficient in pneumolysin or autolysin has reduced virulence in meningitis. , 2008, The Journal of infectious diseases.

[4]  H. Wagner,et al.  Acute brain injury triggers MyD88-dependent, TLR2/4-independent inflammatory responses. , 2007, The American journal of pathology.

[5]  H. Wagner,et al.  MyD88-dependent immune response contributes to hearing loss in experimental pneumococcal meningitis. , 2007, The Journal of infectious diseases.

[6]  S. Akira,et al.  Toll‐like receptor 9 acts at an early stage in host defence against pneumococcal infection , 2007, Cellular microbiology.

[7]  R. Nau,et al.  Microglial cells and peritoneal macrophages release activin A upon stimulation with Toll-like receptor agonists , 2007, Neuroscience Letters.

[8]  C. Snapper,et al.  TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae. , 2007, Cellular immunology.

[9]  H. Pfister,et al.  Complement C1q and C3 Are Critical for the Innate Immune Response to Streptococcus pneumoniae in the Central Nervous System1 , 2007, The Journal of Immunology.

[10]  H. Pfister,et al.  Oxidative stress in pneumococcal meningitis: A future target for adjunctive therapy? , 2006, Progress in Neurobiology.

[11]  B. Mishra,et al.  Expression and distribution of Toll‐like receptors in the brain during murine neurocysticercosis , 2006, Journal of Neuroimmunology.

[12]  J. Timsit,et al.  Detrimental role of delayed antibiotic administration and penicillin-nonsusceptible strains in adult intensive care unit patients with pneumococcal meningitis: The PNEUMOREA prospective multicenter study* , 2006, Critical care medicine.

[13]  R. Spíšek,et al.  Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptors. , 2006, Clinical immunology.

[14]  S. Paludan,et al.  Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis activate the inflammatory response through Toll‐like receptors 2, 4, and 9 in species‐specific patterns , 2006, Journal of leukocyte biology.

[15]  H. Pfister,et al.  Protein expression pattern in experimental pneumococcal meningitis. , 2006, Microbes and infection.

[16]  R. Landmann,et al.  Toll-like receptor-2 deficiency is associated with enhanced brain TNF gene expression during pneumococcal meningitis , 2005, Journal of Neuroimmunology.

[17]  R. Landmann,et al.  Regulation of Streptococcus pneumoniae distribution by Toll-like receptor 2 in vivo. , 2005, Immunobiology.

[18]  C. Snapper,et al.  Both Innate Immunity and Type 1 Humoral Immunity to Streptococcus pneumoniae Are Mediated by MyD88 but Differ in Their Relative Levels of Dependence on Toll-Like Receptor 2 , 2005, Infection and Immunity.

[19]  P. Andrew,et al.  The role of pneumolysin in pneumococcal pneumonia and meningitis , 2004, Clinical and experimental immunology.

[20]  A. Kato,et al.  Corticosteroid and cytokines synergistically enhance toll-like receptor 2 expression in respiratory epithelial cells. , 2004, American journal of respiratory cell and molecular biology.

[21]  S. Miller,et al.  Microglia Initiate Central Nervous System Innate and Adaptive Immune Responses through Multiple TLRs1 , 2004, The Journal of Immunology.

[22]  N. Suttorp,et al.  Nucleotide-binding Oligomerization Domain Proteins Are Innate Immune Receptors for Internalized Streptococcus pneumoniae* , 2004, Journal of Biological Chemistry.

[23]  H. Wagner,et al.  MyD88 is required for mounting a robust host immune response to Streptococcus pneumoniae in the CNS. , 2004, Brain : a journal of neurology.

[24]  S. Dower,et al.  Penicillin enhances the toll-like receptor 2-mediated proinflammatory activity of Streptococcus pneumoniae. , 2003, The Journal of infectious diseases.

[25]  I. Marriott,et al.  Cultured astrocytes express toll‐like receptors for bacterial products , 2003, Glia.

[26]  H. Pfister,et al.  Pneumococcal meningitis in adults: spectrum of complications and prognostic factors in a series of 87 cases. , 2003, Brain : a journal of neurology.

[27]  M. Lipsitch,et al.  Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[28]  W. Binder,et al.  Dexamethasone in adults with bacterial meningitis. , 2003, The New England journal of medicine.

[29]  A. Wellmer,et al.  Decreased Virulence of a Pneumolysin-Deficient Strain of Streptococcus pneumoniae in Murine Meningitis , 2002, Infection and Immunity.

[30]  K. Frei,et al.  Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation. , 2002, The Journal of infectious diseases.

[31]  R. Flavell,et al.  Role of Caspase‐1 in experimental pneumococcal meningitis: Evidence from pharmacologic Caspase inhibition and Caspase‐1‐deficient mice , 2002, Annals of neurology.

[32]  H. Pfister,et al.  Meningitis-Associated Central Nervous System Complications are Mediated by the Activation of Poly(ADP-ribose) Polymerase , 2002, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[33]  U. Dirnagl,et al.  Immune surveillance of mouse brain perivascular spaces by blood‐borne macrophages , 2001, The European journal of neuroscience.

[34]  M. Lipsitch,et al.  Intranasal Immunization with Killed Unencapsulated Whole Cells Prevents Colonization and Invasive Disease by Capsulated Pneumococci , 2001, Infection and Immunity.

[35]  A. Aderem,et al.  Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism , 2001, Nature Immunology.

[36]  S. Akira,et al.  A Toll-like receptor recognizes bacterial DNA , 2000, Nature.

[37]  D. Golenbock,et al.  Cutting edge: recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. , 1999, Journal of immunology.

[38]  A. Tomasz,et al.  The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis. , 1985, The Journal of infectious diseases.